Overview

  • Product nameHU-331
  • Description
    Potent cannabinoid quinone. Topoisomerase II inhibitor.
  • Biological descriptionPotent cannabinoid quinone (EC50 = 0.2 μg/ml) with antineoplastic activity; antitumoriogenic and antiangiogenic in vitro and in vivo. Highly specific inhibitor of topoisomerase II.
  • Purity> 95%

Properties

    References for HU-331 (ab120922)

    This product has been referenced in:
    • Kogan NM  et al. HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor. Mol Cancer Ther 6:173-83 (2007). Read more (PubMed: 17237277) »
    • Kogan NM  et al. A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study. J Pharmacol Exp Ther 322:646-53 (2007). Read more (PubMed: 17478614) »
    • Kogan NM  et al. Synthesis and antitumor activity of quinonoid derivatives of cannabinoids. J Med Chem 47:3800-6 (2004). Read more (PubMed: 15239658) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120922.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"